Xylitol syrup for the prevention of acute otitis media

Pediatrics

Volumn 133, Issue 2, 2014, Pages 289-295

  Vernacchio, Louis ^a,b,c   Corwin, Michael J ^d   Vezina, Richard M ^d   Pelton, Steven I ^e   Feldman, Henry A ^b   Coyne Beasley, Tamera ^f   Mitchell, Allen A ^d  

^a Pediatric Physicians' Organization at Children's   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BOSTON UNIVERSITY   (United States)

^e BOSTON UNIVERSITY   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Otitis media

Indexed keywords

OTITIS MEDIA;

ACUTE DISEASE; ADMINISTRATION, ORAL; FEMALE; HUMANS; INFANT; MALE; OTITIS MEDIA; SINGLE-BLIND METHOD; SWEETENING AGENTS; XYLITOL;

EID: 84893272752     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-2373     Document Type: Article

References (26)

1. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989; 160(1):83-94
2. Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 1997;99(3):318-333
3. Lanphear BP, Byrd RS, Auinger P, Hall CB. Increasing prevalence of recurrent otitis media among children in the United States. Pediatrics. 1997;99(3). Available at: www.pediatrics.org/cgi/content/full/99/3/e1
4. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002;287(23): 3096-3102
5. Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA. 1998;279(11):875-877
6. Mitchell AA. Xylitol prophylaxis for acute otitis media: tout de suite? Pediatrics. 1998; 102(4 pt 1):974-975
7. Mäkinen KK, Bennett CA, Hujoel PP, et al. Xylitol chewing gums and caries rates: a 40-month cohort study. J Dent Res. 1995; 74(12):1904-1913
8. Kontiokari T, Uhari M, Koskela M. Effect of xylitol on growth of nasopharyngeal bacteria in vitro. Antimicrob Agents Chemother. 1995;39(8):1820-1823
9. Kontiokari T, Uhari M, Koskela M. Antiadhesive effects of xylitol on otopathogenic bacteria. J Antimicrob Chemother. 1998;41(5):563-565
10. Tapiainen T, Kontiokari T, Sammalkivi L, Ikäheimo I, Koskela M, Uhari M. Effect of xylitol on growth of Streptococcus pneumoniae in the presence of fructose and sorbitol. Antimicrob Agents Chemother. 2001;45(1):166-169
11. Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010;29(4):304-309
12. Uhari M, Kontiokari T, Koskela M, Niemela M. Xylitol chewing gum in prevention of acute otitis media: double blind randomised trial. BMJ. 1996;313(7066):1180-1184
13. Uhari M, Kontiokari T, Niemelä M. A novel use of xylitol sugar in preventing acute otitis media. Pediatrics. 1998;102(4 pt 1): 879-884
14. Tapiainen T, Luotonen L, Kontiokari T, Renko M, Uhari M. Xylitol administered only during respiratory infections failed to prevent acute otitis media. Pediatrics. 2002;109(2). Available at: www.pediatrics.org/cgi/content/ full/109/2/e19
15. Hautalahti O, Renko M, Tapiainen T, Kontiokari T, Pokka T, Uhari M. Failure of xylitol given three times a day for preventing acute otitis media. Pediatr Infect Dis J. 2007;26(5): 423-427
16. Vernacchio L, Vezina RM, Mitchell AA. Tolerability of oral xylitol solution in young children: implications for otitis media prophylaxis. Int J Pediatr Otorhinolaryngol. 2007;71(1):89-94
17. Woodley J. Bioadhesion: new possibilities for drug administration? Clin Pharmacokinet. 2001;40(2):77-84
18. Vernacchio L, Vezina RM, Ozonoff A, Mitchell AA. Validity of parental reporting of recent episodes of acute otitis media: a Slone Center Office-Based Research (SCOR) Network study. J Am Board Fam Med. 2007;20 (2):160-163
19. Torretta S, Marchisio P, Drago L, et al. Nasopharyngeal biofilm-producing otopathogens in children with nonsevere recurrent acute otitis media. Otolaryngol Head Neck Surg. 2012;146(6):991-996
20. Zuliani G, Carlisle M, Duberstein A, et al. Biofilm density in the pediatric nasopharynx: recurrent acute otitis media versus obstructive sleep apnea. Ann Otol Rhinol Laryngol. 2009;118(7):519-524
21. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296-1310
22. Coleman CI, Limone B, Sobieraj DM, et al. Dosing frequency and medication adherence in chronic disease. J Manag Care Pharm. 2012;18(7):527-539
23. Zwarenstein M, Oxman A; Pragmatic Trials in Health Care Systems (PRACTIHC). Why are so few randomized trials useful, and what can we do about it? J Clin Epidemiol. 2006;59(11):1125-1126
24. Zwarenstein M, Treweek S. What kind of randomized trials do we need? J Clin Epidemiol. 2009;62(5):461-463
25. Pichichero ME, Poole MD. Comparison of performance by otolaryngologists, pediatricians, and general practitioners on an otoendoscopic diagnostic video examination. Int J Pediatr Otorhinolaryngol. 2005;69 (3):361-366
26. Pichichero ME. Diagnostic accuracy of otitis media and tympanocentesis skills assessment among pediatricians. Eur J Clin Microbiol Infect Dis. 2003;22(9):519-524